Cancer diagnostics company raises $2.5m seed funding:
This article was originally published in Clinica
Executive Summary
VC firm Kodiak Venture Partners has invested $2.5m in Cambridge Devices, a Cambridge, Massachusetts start-up focused on technologies for improving cancer diagnostics. The company, established in 2004, is developing two medical devices; the tissue identification probe is designed to enable more accurate diagnosis of breast cancer, while the fluorescence polarisation imaging system is to help doctors excise skin cancers more effectively and reduce recurrence of cancerous cells.